Implementation Design of a Safety Strategy for Handling Hazardous Drugs in a Social Health Center

Authors:
  • Cristina H.M ,
  • Victoria V.V ,
  • Marta S.V. ,

Article Information:

DOI:
Published:October 15, 2023
Article Type:Original Research
Pages:36 - 39
Received:August 5, 2023
Accepted:September 12, 2023

Abstract:

The handling of hazardous drugs (HDs)—including cytotoxic agents, antineoplastics, antivirals, and hormones—poses grave occupational risks to healthcare workers. Effective mitigation in a social health center requires rigorous policy design, multidisciplinary engagement, engineering and administrative controls, robust training, and responsive surveillance. This research article provides a pragmatic, evidence-based roadmap for designing and implementing a comprehensive safety strategy for hazardous drug management within such a setting.

Keywords:

Hazardous drugs (HDs) Occupational safety Healthcare workers Safety strategy Administrative and engineering controls

Article :

INTRODUCTION:

Social health centers are essential nodes in community care, serving vulnerable populations and often operating with resource constraints. Workers in these centers routinely encounter hazardous drugs, which are associated with risks ranging from acute toxicity and dermatitis to reproductive harm, genetic mutations, and carcinogenicity. The chief challenge is ensuring staff, patient, and environmental safety without compromising care standards or accessibility[1][2].

HAZARDOUS DRUGS AND OCCUPATIONAL RISKS:

Hazardous drugs are defined by their potential to cause cancer, mutations, organ toxicity, reproductive toxicity, or similar adverse health effects in humans. The most common classes include antineoplastic agents, immunosuppressants, certain antivirals, and some hormones[1][3].

Healthcare workers may be exposed through:

·        Dermal contact (most common)

·        Inhalation of aerosols and dusts

·        Ingestion (hand-to-mouth transfer)

·        Accidental injection (sharps injuries)

·        Adverse effects may range from mild skin irritation to serious outcomes such as infertility and cancer.

 

Key Elements of a Comprehensive Safety Strategy

Multidisciplinary Policy Committee

·        Establish a Hazardous Drug Safety Committee comprising representatives from pharmacy, nursing, occupational health, risk management, environmental services, and administration.

·        This body leads risk assessment, policy development, audits, education, and incident response[2][4].

 

Risk Assessment and Identification

·        Conduct a facility-specific risk assessment to catalog all HDs at the center, identify routes of exposure, and document at-risk personnel and locations[2][5].

·        Update the hazardous drug list regularly in line with the NIOSH guidelines.

 

Hierarchy of Controls Model

Level

Example Interventions

Notes

Elimination

Substitute non-hazardous alternatives

Often not feasible for key medications

Engineering

Ventilated cabinets (BSCs, C-PECs), closed transfer devices

Most effective where applicable

Administrative

SOPs, scheduling, isolation of HD activities

Reduce exposure aids consistent compliance

PPE

Double gloves, gowns, eye protection, respirators

Last line of defense, never sole protection

 

Standard Operating Procedures (SOPs)

·        SOPs for all HD processes: receiving, storage, preparation, transport, administration, spill response, waste handling[6][7].

·        Procedures based on up-to-date national standards (USP <800>, OSHA, NIOSH).

·        Documentation and audits of all processes[4][7].

 

Engineering Controls

·        Use Class II Biological Safety Cabinets (BSCs) or Containment Primary Engineering Controls (C-PECs) for all hazardous drug compounding.

·        Closed-system drug-transfer devices (CSTDs) for administration.

·        Dedicated HD storage, labeled and separated from non-hazardous inventory.

 

Administrative Controls

·        Rotational work schedules to minimize individual exposure.

·        Clear labeling and hazard signage for all HDs from delivery to disposal.

·        Incident reporting mechanisms for exposures and near-misses.

 

Personal Protective Equipment (PPE)

·        Two pairs of HD-tested gloves, long-sleeved impermeable gowns, eye masks/face shields, and respirators for tasks involving potential exposure.

·        Fit-testing for respirators.

·        Ensure PPE is available and staff are trained in its proper use and disposal[6][5].

 

Spill Management

·        HD spill kits in all handling and administration areas.

·        Staff training on immediate containment, decontamination, and reporting protocols.

·        All exposures and spills require documentation and root-cause review.

 

Education and Training

·        Mandatory initial and annual refresher training for all staff involved in any HD activity (including temp or agency personnel)[2][4].

·        Training covers: risk awareness, SOPs, PPE use, spill response, first aid, waste handling, and reporting.

·        Competency validation and periodic knowledge assessments[8].

 

Environmental and Medical Surveillance

·        Regular surface wipe sampling in preparation/administration areas.

·        Environmental monitoring for HD residues.

·        Medical surveillance programs: baseline and periodic health checks for exposed staff[6].

·        Special provisions for pregnant, lactating, or reproductively vulnerable employees.

 

Implementation Steps

Planning and Resource Allocation

·        Secure leadership support and funding.

·        Procure engineering controls (BSCs, CSTDs), PPE, and spill kits.

·        Schedule committee meetings and assign responsibilities.

 

Rollout

1.      Conduct risk and gap analysis.

2.      Draft SOPs and review with all stakeholders.

3.      Implement hardware and signage changes.

4.      Deliver all-staff and role-specific training.

5.      Commence environmental and medical monitoring.

6.      Establish audit and feedback mechanisms.

 

Continuous Improvement

·        Annual policy reviews based on incidents, audits, new evidence, and changes in HD inventory.

·        Encourage staff feedback and reporting.

 

Example Workflow for Handling a Hazardous Drug

Step

Protocol

Drug Receipt

Inspect, log, and store in HD-designated area

Preparation

In BSC/C-PEC, full PPE, spill kit present

Transport

Sealed, labeled container via defined safe route

Administration

CSTD use, PPE, minimize exposure time

Waste Disposal

Place in labeled, leak-proof, chemo-approved containers

 

Safety Communication

·        Prominent labels and signs on all hazardous drug storage, preparation, and waste areas.

·        Safety Data Sheets (SDSs) accessible to all staff.

·        Regular updates (newsletters/briefings) about safe handling protocols.

 

Challenges and Solutions

·        Resource Constraints: Maximize use of administrative controls, staff rotation, and targeted engineering solutions.

·        Staff Turnover: Ongoing training, mentorship, and easily accessible SOPs.

·        Cultural Change: Foster a safety-first environment through leadership engagement and reinforcing compliance as standard practice.

 

Outcomes Measurement

·        Track incidents of exposure, spills, and near-misses.

·        Evaluate environmental wipe test data for HD contamination.

·        Monitor staff health outcomes and satisfaction with safety procedures.

·        Benchmark against external standards (e.g., NIOSH, OSHA compliance).

 

Visual: Hazardous Drug Handling Process Chart

A process flow diagram can support clarity and reinforce compliance. It should map the journey from drug receipt, through preparation and administration, to waste management, with icons indicating PPE, storage units, spill kits, and checkpoints for monitoring.

CONCLUSION:

A robust, multidisciplinary safety strategy for hazardous drug management protects staff, patients, and the environment, while moving social health centers toward compliance with existing regulations and standards. With strong leadership, systematic controls, and a culture of continuous improvement, even resource-limited settings can successfully safeguard all stakeholders[1][2][6].

REFERENCES:

1.      Kennedy, K., Vu, K., Coakley, N., Daley-Morris, J., Forbes, L., Hartzell, R., Lessels, D. "Safe handling of hazardous drugs." 2023.

2.      "Managing Hazardous Drug Exposures: Information for Healthcare Settings." Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, 2023.

3.      "ASHP Guidelines on Handling Hazardous Drugs." American Society of Health-System Pharmacists, 2023.